Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn
  • Landscape

news

  • Nanochon Performs First Chondrograft™ Implant in First-in-Human Study
    Medical Devices, News

    Nanochon Performs First Chondrograft™ Implant in First-in-Human Study

    Nanochon has announced the first surgical implantation of its Chondrograft™ 3D-printed cartilage implant, performed at The Panama Clinic as part of the company’s First-in-Human clinical study.

    September 15, 2026
  • Linton Lifesciences and ClonalStem Explore Engineered Environments for Vascular Cells
    News, Research, TissueModels

    Linton Lifesciences and ClonalStem Explore Engineered Environments for Vascular Cells

    August 31, 2026
  • Pluristyx Is Building the Manufacturing Layer Behind Biofabricated Liver Therapies
    News, Pharma

    Pluristyx Is Building the Manufacturing Layer Behind Biofabricated Liver Therapies

    August 18, 2026
  • Tides Medical’s APLICOR 3D Used for World’s First 3D-Printed Breast Fat Graft
    Medical Devices, News

    Tides Medical’s APLICOR 3D Used for World’s First 3D-Printed Breast Fat Graft

    August 13, 2026
  • Bruker Just Bought Control of MIMETAS, and With It, a Seat at the Center of the NAMs Transition
    Markets, News

    Bruker Just Bought Control of MIMETAS, and With It, a Seat at the Center of the NAMs Transition

    August 12, 2026

persepctives

  • Europe’s New Bioprinting Cluster Signals a Shift From Printing Tissues to Building Therapies
    Perspectives

    Europe’s New Bioprinting Cluster Signals a Shift From Printing Tissues to Building Therapies

    July 21, 2026
  • Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics
    Perspectives, Pharma

    Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics

    May 14, 2026
  • The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview
    Perspectives, Pharma, Research, TissueModels

    The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview

    April 27, 2026
  • NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication
    News, Perspectives, Research

    NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication

    April 6, 2026

EXPLORE THE LANDSCAPE

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    The Business of Biofabrication

    Have a WordPress.com account? Log in now.

  • The Business of Biofabrication
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar